Coherus BioSciences (CHRS) Reports Q1 Loss Per Share of $1.22
Tweet
Share
E-mailGet Alerts CHRS Hot Sheet
Price: $1.67 --0%
Revenue Growth %: +40.6%
Financial Fact:
Other income: 348K
Today's EPS Names:
CRMT, PKE, HELE, More
Revenue Growth %: +40.6%
Financial Fact:
Other income: 348K
Today's EPS Names:
CRMT, PKE, HELE, More
Join SI Premium – FREE
Coherus BioSciences (NASDAQ: CHRS) reported Q1 EPS of ($1.22), versus ($6.03) reported last year.
For earnings history and earnings-related data on Coherus BioSciences (CHRS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Dollar Tree upgraded on earnings upside potential despite ongoing traffic woes
- NXP Semiconductors NV (NXPI) Reiterated at Overweight by Cantor Fitzgerald: 'Best Value Play'
- Alibaba jumps premarket; Rivian, Bath & Body Works fall
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
